166 related articles for article (PubMed ID: 10983317)
1. [Hemostatic changes during the treatment of acute promyelocytic leukemia with all-transretinoic acid].
Medvedeva NA; Cherepanova VV; Tarasova LN; Kudriavtseva AV; Kostin AI; Kolupaeva OR
Ter Arkh; 2000; 72(7):27-31. PubMed ID: 10983317
[TBL] [Abstract][Full Text] [Related]
2. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS).
Watanabe R; Murata M; Takayama N; Tokuhira M; Kizaki M; Okamoto S; Kawai Y; Watanabe K; Murakami H; Kikuchi M; Nakamura S; Ikeda Y
Thromb Haemost; 1997 Apr; 77(4):641-5. PubMed ID: 9134635
[TBL] [Abstract][Full Text] [Related]
4. Thrombosis during all-trans-retinoic acid therapy in a child with acute promyelocytic leukemia and factor VQ 506 mutation.
Koçak U; Gürsel T; Oztürk G; Kantarci S
Pediatr Hematol Oncol; 2000 Mar; 17(2):177-80. PubMed ID: 10734661
[TBL] [Abstract][Full Text] [Related]
5. All-trans-retinoic acid-induced myositis in a child with acute promyelocytic leukemia.
Citak FE; Ezer U; Akkaya E; Ozbulbul N; Bahce M; Kurekci AE
Haematologica; 2006 Aug; 91(8 Suppl):ECR35. PubMed ID: 16923519
[TBL] [Abstract][Full Text] [Related]
6. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.
Al Bahar S; Pandita R; Bavishi K; Kreze O
Indian J Cancer; 2004; 41(3):125-8. PubMed ID: 15472411
[TBL] [Abstract][Full Text] [Related]
7. In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy.
Dombret H; Scrobohaci ML; Daniel MT; Micléa JM; Castaigne S; Chomienne C; Fenaux P; Degos L
Leukemia; 1995 Jan; 9(1):19-24. PubMed ID: 7531260
[TBL] [Abstract][Full Text] [Related]
8. Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment.
Zhao W; Wang X; Guo W; Qu B; Wang H; Shen Z; Chen Z; Wang Z
Chin Med J (Engl); 2000 Mar; 113(3):236-40. PubMed ID: 11775254
[TBL] [Abstract][Full Text] [Related]
9. [Paralytic ileus during treatment of acute promyelocytic leukemia with all-trans retinoic acid].
Kanisawa Y; Kawanishi N; Hisai H; Araya H; Akiyama T; Takahari D
Rinsho Ketsueki; 2000 Aug; 41(8):687-9. PubMed ID: 11020999
[TBL] [Abstract][Full Text] [Related]
10. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).
Gupta V; Yi QL; Brandwein J; Lipton JH; Messner HA; Schuh AC; Wells RA; Minden MD
Leuk Res; 2005 Jan; 29(1):113-4. PubMed ID: 15541484
[TBL] [Abstract][Full Text] [Related]
11. Acute renal failure during ATRA treatment.
Yarali N; Tavil B; Kara A; Ozkasap S; Tunç B
Pediatr Hematol Oncol; 2008 Mar; 25(2):115-8. PubMed ID: 18363177
[TBL] [Abstract][Full Text] [Related]
12. [Acute renal failure in the transretinoic syndrome].
Sastre A; Gago E; Baños M; Gómez E
Nefrologia; 2007; 27(2):184-90. PubMed ID: 17564563
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid syndrome.
Datta D; Gerardi DA
Conn Med; 2003 Oct; 67(9):541-3. PubMed ID: 14619342
[TBL] [Abstract][Full Text] [Related]
14. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients.
Dai CW; Zhang GS; Shen JK; Zheng WL; Pei MF; Xu YX; Cao YX; Yi Y; Yang JJ; Peng HL; Zhong HY; Li RJ
Acta Haematol; 2009; 121(1):1-8. PubMed ID: 19246888
[TBL] [Abstract][Full Text] [Related]
15. [A third complete remission of acute promyelocytic leukemia achieved by administering a gradual increase of all-trans retinoic acid following massive ascites due to retinoic acid syndrome].
Tsujioka T; Wada H; Yata K; Suemori S; Yamada O; Sugihara T
Rinsho Ketsueki; 2003 Jul; 44(7):474-6. PubMed ID: 12931568
[TBL] [Abstract][Full Text] [Related]
16. Scrotal ulceration during induction therapy of acute promyelocytic leukemia with ATRA.
Pavithran K; Arjun R; Aruna R; Thomas M
Am J Hematol; 2004 Apr; 75(4):260-1. PubMed ID: 15054825
[TBL] [Abstract][Full Text] [Related]
17. [Oral All-transretinoic acid administration in intubated patients with acute promyelocytic leukemia].
Bargetzi MJ; Tichelli A; Gratwohl A; Speck B
Schweiz Med Wochenschr; 1996 Nov; 126(45):1944-5. PubMed ID: 8946598
[TBL] [Abstract][Full Text] [Related]
18. [All-trans retinoic acid for thromboembolic events in patients with M3 leukemia: a case report].
Yin F; Zheng WY; Meng FY; Jiang ZJ; Liu XL; Feng R; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):187-8. PubMed ID: 12581981
[TBL] [Abstract][Full Text] [Related]
19. Sweet's syndrome associated with retinoic acid syndrome in a patient with promyelocytic leukemia.
Astudillo L; Loche F; Reynish W; Rigal-Huguet F; Lamant L; Pris J
Ann Hematol; 2002 Feb; 81(2):111-4. PubMed ID: 11907794
[TBL] [Abstract][Full Text] [Related]
20. [Development of Sweet syndrome in an acute promyelocyte leukemia patient during treatment with all-trans retinoic acid--case report and literature review].
Yan ZS; Li DP; Jiang EL; Zhou CL; Liu EB; Chen HS; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):462-5. PubMed ID: 18072629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
